The head of the top federal medical research agency said in a new interview that marijuana’s status as a Schedule I drug inhibits studies into the plant and prevents scientists from researching the effects of cannabis that consumers are obtaining from state-legal dispensaries in a growing number of states. Francis Collins, director of the National … Continue reading Federal Law A ‘Big Deterrent’ To Marijuana Research, Top U.S. Health Science Official Says